CircRNA DDX21 Acts As a Prognostic Factor and Sponge of MiR-1264/QKI Axis to Weaken the Progression of Triple-negative Breast Cancer

Overview

Journal Clin Transl Med

Publisher Wiley

Specialty General Medicine

Date 2022 May 6

PMID 35522944

Authors

Renhong Huang

Zhou Yang

Qian Liu

Biao Liu

Xinyuan Ding

Zheng Wang

Affiliations

Soon will be listed here.

Citing Articles

MicroRNA‑96 promotes the proliferation and migration of breast cancer cells by inhibiting Smad7 expression.

Zhang X, Cong L, Yu R, Yu Q, Hou X, Zhou Y Oncol Lett. 2025; 29(3):151.

PMID: 39898288 PMC: 11783994. DOI: 10.3892/ol.2025.14897.

DDX21 at the Nexus of RNA Metabolism, Cancer Oncogenesis, and Host-Virus Crosstalk: Decoding Its Biomarker Potential and Therapeutic Implications.

Xiao Y, Fan J, Li Z, Hou Y Int J Mol Sci. 2025; 25(24.

PMID: 39769343 PMC: 11676383. DOI: 10.3390/ijms252413581.

The clinical perspective of circular RNAs in neurodegenerative diseases: potential diagnostic tools and therapeutic targets.

Li X, Wang P, Qi S, Zhou J, Amalraj J, Wang J Front Cell Neurosci. 2024; 18:1470641.

PMID: 39624645 PMC: 11608961. DOI: 10.3389/fncel.2024.1470641.

CircDDX21 alleviates trophoblast dysfunction and Treg differentiation in recurrent spontaneous abortion via miR-520a-5p/ FOXP3/PD-L1 axis.

Duan B, Feng Q, Li L, Huang J J Assist Reprod Genet. 2024; 41(12):3539-3557.

PMID: 39400646 PMC: 11706825. DOI: 10.1007/s10815-024-03281-9.

Exploring the oncogenic potential of circSOD2 in clear cell renal cell carcinoma: a novel positive feedback loop.

Yao G, Fu L, Dai J, Chen J, Liu K, Liang H J Transl Med. 2024; 22(1):596.

PMID: 38926764 PMC: 11209967. DOI: 10.1186/s12967-024-05290-9.

References

Nedeljkovic M, Damjanovic A . Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge. Cells. 2019; 8(9). PMC: 6770896. DOI: 10.3390/cells8090957. View

Liang H, Zhang X, Liu B, Jia G, Li W . Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271. Am J Cancer Res. 2017; 7(7):1566-1576. PMC: 5523036. View

Zheng Z, Li X, You H, Zheng X, Ruan X . LncRNA SOCS2-AS1 inhibits progression and metastasis of colorectal cancer through stabilizing SOCS2 and sponging miR-1264. Aging (Albany NY). 2020; 12(11):10517-10526. PMC: 7346041. DOI: 10.18632/aging.103276. View

Chen D, Chou F, Chen Y, Tian H, Wang Y, You B . Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Lett. 2020; 495:100-111. DOI: 10.1016/j.canlet.2020.07.040. View

Shen M, Pan H, Chen Y, Xu Y, Yang W, Wu Z . A review of current progress in triple-negative breast cancer therapy. Open Med (Wars). 2020; 15(1):1143-1149. PMC: 7718625. DOI: 10.1515/med-2020-0138. View

Zhang H, Zhang Y, Chen C, Zhu X, Zhang C, Xia Y . A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer. Cancer Lett. 2018; 437:67-78. DOI: 10.1016/j.canlet.2018.08.021. View

Lee J, You J, Kim M, Roh J . Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biol. 2020; 37:101697. PMC: 7484553. DOI: 10.1016/j.redox.2020.101697. View

Zong F, Fu X, Wei W, Luo Y, Heiner M, Cao L . The RNA-binding protein QKI suppresses cancer-associated aberrant splicing. PLoS Genet. 2014; 10(4):e1004289. PMC: 3983035. DOI: 10.1371/journal.pgen.1004289. View

Xu J, Shao C, Wang X, Zhao X, Chen J, Ouyang Y . circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis. 2019; 10(3):175. PMC: 6382814. DOI: 10.1038/s41419-019-1382-y. View

10.

Pillman K, Phillips C, Roslan S, Toubia J, Dredge B, Bert A . miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking. EMBO J. 2018; 37(13). PMC: 6028027. DOI: 10.15252/embj.201899016. View